With the Pfizer (PFE)/BioNTech (BNTX) booster guidance in the rearview mirror, the CDC and the country’s other regulatory and public health agencies are gearing up to tackle Moderna’s (MRNA) and eventually Johnson & Johnson’s (JNJ) booster filings for recipients of those vaccines.
Meanwhile, many have wondered why the U.S. is not following Europe’s and Canada’s lead in allowing mixing and matching of vaccine brands in order to be considered fully vaccinated or for booster doses.
CDC Director…
Source link
